Search results
Results from the WOW.Com Content Network
By 5 January 2021, 1.3 million people across the UK had received their first dose of either the Pfizer or Oxford–AstraZeneca COVID-19 vaccine, which included more than 650,000 people over 80, representing around 23% of that age band in England. [116]
One dose of Pfizer or Moderna vaccines appears at least 80% effective against symptomatic COVID-19. For AstraZeneca, one-shot efficacy is 70%.
The Pfizer/BioNTech vaccine generates a robust immune response in 99% of people after one dose, new research suggests. One dose of the vaccine protects against severe disease and after two jabs ...
Among the over-80s, Covid testing data on more than 12,000 people found at least 57% protection against coronavirus 28 days after vaccination with a single dose of Pfizer, rising to 88% after a ...
The committee was established in 1963, having been until then an advisory board for polio immunisation. [1] It gained statutory status as the Standing Advisory Committee on Vaccination and Immunisation, a non-departmental public body [2] advising the Secretary of State for Social Services and the Secretary of State for Wales, under the National Health Service (Standing Advisory Committees ...
December 2014 [19] to 2020 [20] – Michael Rawlins (also chaired UK Biobank; previously chair of the National Institute for Health and Care Excellence) September 2020 to July 2023 – Stephen Lightfoot (also chaired Sussex Community NHS Foundation Trust) [21]
Thomas Edward George Hayhoe [1] (born 3 March 1956) is a chair of health sector organisations and of regulatory bodies, a commentator on governance and organisation, a former businessman, student union politician and parliamentary candidate, a disability rights campaigner, and an offshore racing sailor. He has lived in Hammersmith in West ...
(Reuters) -Britain's health regulator said on Wednesday it has authorised Pfizer and BioNTech's updated COVID-19 vaccine that targets the JN.1 subvariant for use in infants, children and adults.